Old Web
English
Sign In
Acemap
>
Paper
>
OA03.07 Pembrolizumab for Advanced Mesothelioma: Results from the Phase 2 KEYNOTE-158 Study
OA03.07 Pembrolizumab for Advanced Mesothelioma: Results from the Phase 2 KEYNOTE-158 Study
2021
Timothy A. Yap
Kazuo Nakagawa
N. Fujimoto
Kozo Kuribayashi
Tormod Kyrre Guren
L. Calabrò
R.S. Frommer
Bo Gao
Steven Kao
Ignacio Matos
David Planchard
Arkendu Chatterjee
Fan Jin
Kevin Norwood
Hedy L. Kindler
Keywords:
Internal medicine
Oncology
Pembrolizumab
Mesothelioma
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]